Dimensional Fund Advisors
IBRX icon

Dimensional Fund Advisors’s ImmunityBio IBRX Stock Holding History

Dimensional Fund Advisors’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$844K Buy
110,009
+85,305
+345% +$584K ﹤0.01% 2870
2025
Q4 		$48.9K Buy
+24,704
New +$56K ﹤0.01% 3213
2025
Q2 		– Sell
-13,328
Closed -$40.1K – 3297
2025
Q1 		$40.1K Sell
13,328
-14,638
-52% -$44.4K ﹤0.01% 3270
2024
Q4 		$71.6K Buy
27,966
+16,954
+154% +$70.6K ﹤0.01% 3267
2024
Q3 		$41K Sell
11,012
-5,568
-34% -$25.8K ﹤0.01% 3313
2024
Q2 		$105K Buy
+16,580
New +$109K ﹤0.01% 3244
2022
Q1 		– Sell
-10,221
Closed -$62K – 3531
2021
Q4 		$62K Sell
10,221
-234
-2% -$1.76K ﹤0.01% 3473
2021
Q3 		$102K Buy
+10,455
New +$115K ﹤0.01% 3427
2021
Q2 		– Sell
-98,437
Closed -$2.34M – 3469
2021
Q1 		$2.34M Sell
98,437
-23,461
-19% -$608K ﹤0.01% 2815
2020
Q4 		$1.63M Sell
121,898
-101,514
-45% -$977K ﹤0.01% 2865
2020
Q3 		$1.55M Buy
223,412
+6,609
+3% +$65.9K ﹤0.01% 2818
2020
Q2 		$2.66M Buy
216,803
+2,460
+1% +$13.9K ﹤0.01% 2668
2020
Q1 		$617K Buy
214,343
+4,954
+2% +$24.8K ﹤0.01% 3016
2019
Q4 		$794K Sell
209,389
-15,128
-7% -$25.7K ﹤0.01% 3056
2019
Q3 		$274K Hold
224,517
– – ﹤0.01% 3239
2019
Q2 		$229K Hold
224,517
– – ﹤0.01% 3298
2019
Q1 		$355K Sell
224,517
-4,709
-2% -$5.91K ﹤0.01% 3221
2018
Q4 		$266K Sell
229,226
-12,589
-5% -$28.8K ﹤0.01% 3245
2018
Q3 		$895K Buy
241,815
+25,543
+12% +$80.8K ﹤0.01% 3087
2018
Q2 		$662K Buy
216,272
+127,694
+144% +$473K ﹤0.01% 3083
2018
Q1 		$345K Buy
88,578
+7,405
+9% +$32.5K ﹤0.01% 3156
2017
Q4 		$364K Buy
+81,173
New +$384K ﹤0.01% 3138

Other funds holding IBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Dimensional Fund Advisors's IBRX Position: Q1 2026 in Review

Dimensional Fund Advisors increased its ImmunityBio (IBRX) stake by 345% in Q1 2026, buying an estimated $584K and bringing the position to 110,009 shares worth $844K. The position accounts for ﹤0.01% of the portfolio, ranked #2870.

Dimensional Fund Advisors first reported a position in IBRX in Q4 2017 and has held it in 22 quarters since. The position peaked at $2.66M in Q2 2020. 386 funds tracked by Wall St. Rank hold IBRX as of Q1 2026.

  • Dimensional Fund Advisors held 110,009 shares of ImmunityBio worth $844K as of Q1 2026.
  • Dimensional Fund Advisors bought 85,305 ImmunityBio shares in Q1 2026, an estimated $584K.
  • ImmunityBio made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2870 holding.
  • Dimensional Fund Advisors first reported a position in ImmunityBio in Q4 2017 and has held it in 22 quarters since.
  • Dimensional Fund Advisors's ImmunityBio position peaked at $2.66M in Q2 2020.
  • 386 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.